Replies to post #264160 on Avid Bioservices Inc (CDMO)

[Carboat]

plenty of politics in medicine. You pay for these two trials I would certainly expect their heavyweights to "express interest" - that IS a very low bar.

there are hundreds of biotechs that are trying to make it so why don't a hundred of them hand over their pipeline drug to NCCN as well and just fork up $2 Million ??

some don't need to pay to have someone else run their trials. Some are not good fits sure. But this is not some big beat of scores of competing bios. They just need to step it up get the trials designed and start the results clock. The value of the trials existence, and collaborations, is in the stock so move on.